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After publication of our article [1], we realised that the 
title used was incorrect. The correct title “Agonist Opioid 
Treatment as historical comprehensive treatment (‘Dole 
and Nyswander’ methodology) is associated with better 
toxicology outcome than Harm Reduction Treatment” 
appears above.
In addition, it has come to our attention that we did 
not declare a potential competing interest which is that 
Molteni Pharmaceutical agreed to provide funds to cover 
the article-processing charge before we submitted our 
article to Annals of General Psychiatry.
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